📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Peer Medians

About

BankUnited, Inc. operates as the bank holding company for BankUnited, a national banking association that provides a range of banking services in the United States. The company offers deposit products, such as checking, money market deposit, and savings accounts; certificates of deposit; and treasury, payments and cash management services. Its loans portfolio includes commercial loans, including equipment loans, secured and unsecured lines of credit, formula-based lines of credit, owner-occupied commercial real estate term loans and lines of credit, mortgage warehouse lines, subscription finance facilities, letters of credit, commercial credit cards, small business administration and U.S. department of agriculture product offerings, export-import bank financing products, trade finance, and business acquisition finance credit facilities; commercial real estate loans; residential mortgages; and other consumer loans. The company offers loan servicing and deposit transaction processing systems, cloud-based data storage, electronic funds transfer transaction processing, online banking services, ERP systems and computer and networking infrastructure. It operates through a network of banking centers located in Florida counties and the New York metropolitan area, as well as Dallas, Texas. The company was formerly known as BU Financial Corporation. BankUnited, Inc. was incorporated in 2009 and is headquartered in Miami Lakes, Florida.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding BKU

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Steve Cohen Point72 Asset Management	466.7K	$21.1M	0.03%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 3 quarters analysed

Q2 2025

Confident Specific

Management used phrases like 'outstanding quarter', 'very happy', 'nice beat', and 'impressive deposit growth' while citing specific metrics (EPS $0.91 vs consensus $0.79, ROA 78bp, ROE 9.4%, NIDDA up 20%). They provided detailed, positive numbers across deposits, margin, and capital.

Q4 2025

Confident Specific

Management used specific metrics (e.g., 'EPS $0.90, adjusted $0.94', 'margin 3.06%', 'NIDDA spot growth $485M', 'core loan growth $769M') and repeated 'great year', 'awesome year', 'hit everything we were trying to hit'. They acknowledged one guidance miss (core loan growth at 5% vs high-single-digit) but framed it as minor within an otherwise strong year.

Q1 2026 latest

Confident Specific

Raj Singh repeatedly emphasized seasonality and year-over-year comparisons, stating 'don't look at quarter-over-quarter, look at year-over-year' and provided specific prior-year parallels showing similar sequential declines. He also gave precise credit improvements (NPAs down 26%, criticized down 12%) and deposit growth figures ($1.4B non-broker deposits over 12 months).

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis remains largely intact after this call, supported by strong credit improvement, continued NIDDA growth, and reaffirmed full-year guidance. The Q1 earnings dip was explicitly tied to well-understood seasonality, and management provided confidence that Q2 will see a rebound. The main risks to watch are whether deposit cost management can sustain margin expansion without Fed cuts, and whether the elevated net charge-offs (37 bps trailing) normalize toward the 25 bps target as expected. Next quarter's NIDDA growth and NIM trajectory will be critical to validate the guidance. Overall, the thesis is unchanged but execution on NIDDA and credit will be key.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

📐

3-Statement Financial Model

Bear / Base / Bull projections · DCF fair value · Reverse-DCF

Open Model →

🎙 Management Tone Confident Specific → Stable 3 quarters Full tone analysis in Intelligence →

📊 MIXED Q1 earnings $62M, EPS $0.83, NIM 2.99%, non-broker deposits up $1.4B YoY

Revenue & Profitability

Net income was $62 million (EPS $0.83), up 5% from $58 million (EPS $0.78) in Q1 2025. Pre-provision net revenue (PPNR) was $106 million, an 11.5% increase year-over-year. Net interest income increased $16 million or 7% from a year ago. The provision for credit losses was $25 million, including an $8 million qualitative overlay for geopolitical uncertainty. Net charge-offs were $36 million, bringing the trailing 12-month charge-off rate to 37 basis points.

Outlook

Management sees no change to full-year guidance, with seasonal patterns expected to drive strong NIDDA growth in Q2 and higher loan production later in the year. The Middle East conflict is noted as a new uncertainty, but management believes a short-term resolution is likely. Credit trends are improving, with non-performing loans down 26% in the quarter and expectations for further reductions in Q2, Q3, and Q4.

Growth Drivers

Key growth levers include NIDDA growth driven by net new client acquisition (approximately 50 net new clients per quarter in NTS), expansion in southern markets (Atlanta, Charlotte, Texas), and growth in capital markets fees, syndications, and the FX platform (client count up over 100% year-over-year). The company is also adding specialty talent and investing in back-office fulfillment to support expansion.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

The net interest margin declined to 2.99% in Q1 from 3.06% in Q4 2025, following a seasonal pattern. NIM expanded 18 basis points year-over-year. Management expects NIM to rebound strongly in Q2, similar to the prior year (from 2.81% in Q1 2025 to 2.93% in Q2 2025), and reach ~3.20% by year-end. Deposit costs declined 6 basis points to 2.12% on average, and the company continues to push for further reductions despite the absence of Fed rate cuts.

Key Risks

Key risks flagged include geopolitical uncertainty (Middle East conflict) leading to an $8 million qualitative reserve addition, potential elevated net charge-offs in the first half of the year (especially from C&I loans in healthcare and transportation), and competitive pressure on loan spreads and deposit pricing if the Fed does not cut rates. A failure to achieve NIDDA growth targets would be the single largest risk to guidance.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-07-22

Record NIDDA to deposit ratio and nearly $10B in NIDDA drove strong deposit and margin growth, while loan growth lagged due to competition and strategic exits. Guidance was fine-tuned: higher deposit and fee income expectations, but lower loan and NII growth.

Q1 2026 Q1 2026 2026-04-22

First quarter results showed year-over-year growth in net income, deposits, and credit quality, with management reaffirming full-year guidance and highlighting strong NIDDA growth and robust pipelines despite competitive and geopolitical pressures.

Q4 2025 Q4 2025 2026-01-21

Delivered strong double-digit growth in EPS, earnings, and PP&R for 2025, with robust Q4 results and margin expansion. Core loans and deposits grew significantly, credit quality remained solid, and a $200M buyback plus dividend increase were announced.

Q3 2025 Q3 2025 2025-10-22

Earnings, ROA, and margin all improved, with net income of $71.9M and EPS of $0.95 beating consensus. Credit quality remained stable, expenses were well controlled, and fee income grew 24% year-over-year. Management expects continued margin and ROE growth, with balanced loan and deposit pipelines.

Q2 2025 Q2 2025 2025-07-23

Q2 2025 saw strong earnings, margin expansion, and robust deposit growth, with net income of $68.8M and NIDDA up over $1B. Office-related NPLs increased as expected, but reserves and capital remain strong. Guidance calls for continued margin and deposit growth.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.